SYS-CON MEDIA Authors: Pat Romanski, Nikita Ivanov, Yeshim Deniz, Elizabeth White, Sean Houghton

News Feed Item

Acute Heart Failure Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Acute Heart Failure Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

Acute Heart Failure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Acute Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Acute Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 6
Acute Heart Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acute Heart Failure 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29

Prominent Sponsors 30
Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Acute Heart Failure 33
Jul 28, 2014: Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Nile Therapeutics, Inc. 35
Clinical Trial Overview of Nile Therapeutics, Inc. 35
Cardiorentis AG 36
Clinical Trial Overview of Cardiorentis AG 36
Amgen Inc. 37
Clinical Trial Overview of Amgen Inc. 37
Abbott Laboratories 38
Clinical Trial Overview of Abbott Laboratories 38
Cytokinetics, Inc. 39
Clinical Trial Overview of Cytokinetics, Inc. 39
Biogen Idec Inc. 40
Clinical Trial Overview of Biogen Idec Inc. 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Alere Inc. 42
Clinical Trial Overview of Alere Inc. 42

Actelion Ltd 43
Clinical Trial Overview of Actelion Ltd 43
Clinical Trial Overview of Top Institutes / Government 44
Duke University 44
Clinical Trial Overview of Duke University 44
National Cerebral and Cardiovascular Center 45
Clinical Trial Overview of National Cerebral and Cardiovascular Center 45
University Hospital Basel 46
Clinical Trial Overview of University Hospital Basel 46
Assistance Publique - Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 47
French Cardiology Society 48
Clinical Trial Overview of French Cardiology Society 48
Northwestern University 49
Clinical Trial Overview of Northwestern University 49
University Hospital of Larissa 50
Clinical Trial Overview of University Hospital of Larissa 50
The Cleveland Clinic 51
Clinical Trial Overview of The Cleveland Clinic 51
Hebei Medical University 52
Clinical Trial Overview of Hebei Medical University 52
YAMAGUCHI UNIVERSITY 53
Clinical Trial Overview of YAMAGUCHI UNIVERSITY 53
Five Key Clinical Profiles 54
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83

List of Tables

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Acute Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Nile Therapeutics, Inc., 2014* 35
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiorentis AG, 2014* 36

Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 37
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 38
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc., 2014* 39
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 40
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 41
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alere Inc., 2014* 42
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 43
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 44
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cerebral and Cardiovascular Center, 2014* 45
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 46
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 47
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by French Cardiology Society, 2014* 48
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 49
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Larissa, 2014* 50
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 51
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hebei Medical University, 2014* 52
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by YAMAGUCHI UNIVERSITY, 2014* 53

List of Figures

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 82

To order this report: Acute Heart Failure Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
An entirely new security model is needed for the Internet of Things, or is it? Can we save some old and tested controls for this new and different environment? In his session at @ThingsExpo, New York's at the Javits Center, Davi Ottenheimer, EMC Senior Director of Trust, reviewed hands-on lessons with IoT devices and reveal a new risk balance you might not expect. Davi Ottenheimer, EMC Senior Director of Trust, has more than nineteen years' experience managing global security operations and asse...
"Matrix is an ambitious open standard and implementation that's set up to break down the fragmentation problems that exist in IP messaging and VoIP communication," explained John Woolf, Technical Evangelist at Matrix, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
DevOps is all about agility. However, you don't want to be on a high-speed bus to nowhere. The right DevOps approach controls velocity with a tight feedback loop that not only consists of operational data but also incorporates business context. With a business context in the decision making, the right business priorities are incorporated, which results in a higher value creation. In his session at DevOps Summit, Todd Rader, Solutions Architect at AppDynamics, discussed key monitoring techniques...
We are reaching the end of the beginning with WebRTC, and real systems using this technology have begun to appear. One challenge that faces every WebRTC deployment (in some form or another) is identity management. For example, if you have an existing service – possibly built on a variety of different PaaS/SaaS offerings – and you want to add real-time communications you are faced with a challenge relating to user management, authentication, authorization, and validation. Service providers will w...
The 3rd International @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to th...
SYS-CON Media announced that Centrify, a provider of unified identity management across cloud, mobile and data center environments that delivers single sign-on (SSO) for users and a simplified identity infrastructure for IT, has launched an ad campaign on Cloud Computing Journal. The ads focus on security: how an organization can successfully control privilege for all of the organization’s identities to mitigate identity-related risk without slowing down the business, and how Centrify provides ...
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, discussed how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will need to convince a skeptical public to participate. Get ready to show them the money!
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
The term culture has had a polarizing effect among DevOps supporters. Some propose that culture change is critical for success with DevOps, but are remiss to define culture. Some talk about a DevOps culture but then reference activities that could lead to culture change and there are those that talk about culture change as a set of behaviors that need to be adopted by those in IT. There is no question that businesses successful in adopting a DevOps mindset have seen departmental culture change, ...
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, focused on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle development and testing environments. Anne Plese is a marketing and technology enthusiast/realist with over 19+ years in high tech. At Verizon Enterprise, she focuses on driving growth for the Verizon Cloud platfo...
"There is a natural synchronization between the business models, the IoT is there to support ,” explained Brendan O'Brien, Co-founder and Chief Architect of Aria Systems, in this SYS-CON.tv interview at the 15th International Cloud Expo®, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Gridstore™, the leader in hyper-converged infrastructure purpose-built to optimize Microsoft workloads, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Gridstore™ is the leader in hyper-converged infrastructure purpose-built for Microsoft workloads and designed to accelerate applications in virtualized environments. Gridstore’s hyper-converged infrastructure is the ...
This builds on Puppet Labs' first class Windows support, including native .MSI packages for x32 and x64 operating systems, modules to extend common Windows server management tools, including Powershell, and integrations with Microsoft Azure and Visual Studio. By automating common Windows administration tasks, Puppet Labs is enabling users to adopt DevOps practices, thereby reducing the time needed to deploy applications from weeks to hours.
DevOps Summit 2015 New York, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete...
WebRTC defines no default signaling protocol, causing fragmentation between WebRTC silos. SIP and XMPP provide possibilities, but come with considerable complexity and are not designed for use in a web environment. In his session at @ThingsExpo, Matthew Hodgson, technical co-founder of the Matrix.org, discussed how Matrix is a new non-profit Open Source Project that defines both a new HTTP-based standard for VoIP & IM signaling and provides reference implementations.